Derrick Katayama accomplished formulation and analytical scientist with 16 years of experience in the areas of therapeutic proteins, peptides, subunit vaccines, and monoclonal antibodies. He joined Samsung Biologics team in 2022 as a Scientist of Formulation development team in CDO.
